Blockbuster Diabetes Drug Approved by the FDA

Finally some good news for Type 2 Diabetics, drug makers Bristol-Myers Squibb and partners Astrazeneca PLC had their latest drug Onglyza approved. Onglyza reduces blood sugar levels in patients with type 2 diabetes, which affects 24 million people in the U.S. The drug is the first to gain approval since the agency issued new testing […]